COVID-19: Your safety is our priority. Amidst the COVID-19 outbreak, we are doing our part to keep our clients and team members safe and healthy. The wheels of justice are still moving, but you can stay home while we fight for you. Learn More about the precautions Whitley Law Firm is taking to minimize the spread of COVID-19 and read more about Frequently Asked Questions regarding how the outbreak could affect your case.

Multidistrict litigation refers to a mass consolidated action of individual lawsuits against a few common defendants. In this case, it is in the proton pump inhibitor multidistrict litigation, which is the class of heartburn medications to which Nexium belongs. It has been centralized in the District of New Jersey and federal court. For more information about Nexium multidistrict litigation, reach out to a dedicated lawyer.

Why is Multidistrict Litigation Used?

Multidistrict litigations are used because they are a very efficient way for plaintiffs to bring lawsuits against billion dollar companies. It is more advantageous and efficient for plaintiffs to pool resources and attorneys for one common cause of action, such as how Nexium causes kidney failure or kidney damage. Instead of those plaintiffs trying multiple similar cases, they show it on a global scale.

Common Types of Multidistrict Litigations

The types of cases that use multidistrict litigations are largely drug litigations. They include drugs like Nexium and Prilosec. Some other drugs that have used multidistrict litigations are Taxotere, a cancer treatment drug, and Xarelto, which is the blood thinner. There are many more examples.

Currently, there are also a lot of multidistrict litigations involving medical devices. Devices are medical devices such as metal-on-metal hip, metal elbow, spinal cord stimulator, or knee replacement. It is some sort of a device that is actually implanted in the patient’s body as part of an orthopedic procedure, and they suffer consequences as a result.

Class Action Suits and Multidistrict Litigations

Multidistrict litigations and class action suits are not the same. A class action suit has a class representative, and they are able to bind the rest of the group on whether or not a settlement happens. They involve lesser damages for each of the class members than what plaintiffs are seeking in multidistrict litigation.

In a class action case, there might be economic harm, but it is not going to be the same extent as someone with kidney failure, for example. Class actions are frequently used for consumers cases and for more nominal damages. Nexium multidistrict litigations typically involve higher damages due to the adverse side effects of the drug.

Nexium Multidistrict Litigation Process

There are currently more than 4,000 lawsuits filed in New Jersey in the proton pump inhibitor multidistrict litigation, and Nexium is one of the products at issue. To enter into the litigation, someone must have suffered kidney damage while taking Prilosec or Nexium and contacted an experienced dangerous drug lawyer. An attorney could review the potential plaintiff’s medical history and determine whether they qualify for the multidistrict litigation.

In 2020, the first bellwether trial in the Nexium multidistrict litigation will take place. A bellwether trial is a smaller trial made up of a collection of lawsuits from the larger litigation. Bellwether trials are often a strong indicator of how subsequent cases will be adjudicated.

Benefits of Nexium Multidistrict Litigation

The benefits of a multidistrict litigation case are that resources are shared among plaintiffs. No single plaintiff has to spend millions of dollars to prove the case against the defendant.

To be part of a Nexium multidistrict litigation case, a plaintiff may owe no money out-of-pocket. Instead, the lawyer may assume all of the financial risks of bringing a claim. Subsequently, the lawyer is only paid if the plaintiff recovers compensation. To learn more about the benefits of multidistrict litigation and how an attorney could help you recover damages, call today.